Table 4. Anthropometric assessment stratified by follow-up visit and age.
Biannual Mass Azithromycin | No Mass Azithromycin | |||||
---|---|---|---|---|---|---|
Age | N | Height, cm | Weight, kg | N | Height, cm | Weight, kg |
Month 12 | ||||||
0 y | 32 | 66.6 (65.1–68.1) | 7.1 (6.7–7.5) | 23 | 68.1 (65.3–71.0) | 7.3 (6.8–7.7) |
1 y | 62 | 76.7 (75.5–78.0) | 9.2 (8.9–9.5) | 50 | 77.1 (75.9–78.2) | 9.1 (8.8–9.4) |
2 y | 52 | 83.6 (82.8–85.1) | 10.5 (10.1–10.9) | 63 | 83.9 (82.3–85.6) | 10.7 (10.3–11.1) |
Month 36 | ||||||
0 y | 15 | 66.5 (64.9–68.1) | 7.4 (7.0–7.9) | 15 | 66.0 (64.5–67.5) | 7.3 (6.8–7.7) |
1 y | 52 | 74.9 (73.6–76.1) | 8.9 (8.5–9.2) | 28 | 75.8 (73.9–77.6) | 8.9 (8.5–9.3) |
2 y | 44 | 84.8 (82.9–86.7) | 10.8 (10.4–11.3) | 52 | 83.7 (82.5–85.0) | 10.8 (10.4–11.1) |
3 y | 64 | 93.7 (92.1–95.2) | 12.7 (12.3–13.1) | 62 | 91.7 (90.3–93.0) | 12.4 (12.0–12.9) |
4 y | 60 | 99.6 (98.2–101.0) | 14.3 (13.9–14.7) | 63 | 99.2 (97.9–100.5) | 14.3 (13.9–14.7) |